C
Live / Registered — Registered and renewed (as of 29 Nov 2014)
What this means for you
Registered since 08 Nov 2005. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Nov 2015).
Record
- Serial number
- 78447755
- Registration number
- 3014168
- Mark type
- Design + words
- Filed
- 08 Jul 2004
- Published for opposition
- 10 May 2005
- Registered
- 08 Nov 2005
- Next maintenance due
- 08 Nov 2015
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: biological preparations for medical purposes, namely for use in the treatment of immunological, inflammatory and neurological disorders; pharmaceuticals, genomic and biological agents for use in the fields of immunological, inflammatory and neurological disorders for the identification, analysis, prevention, detection, diagnosis, prognosis and treatment; biological preparations for use in medicinal tests, inoculations, and treatment of diseases, namely, immunological, inflammatory and neurological disorders and cancer; culture media, namely, tissue culture media and bacteriological culture media for medical use; medicinal and biological preparations for pharmaceutical, clinical or medical laboratory use, namely, preparations for the inhibition of gene expression working at DNA, transcription, RNA or translation processes, and modulation of immune system
- Class 040 — Treatment of materials: custom synthesis of DNA to the order and specification of others; custom manufacturing services [, namely, manufacturing agrochemicals to the specification of others ]
- Class 042 — Scientific and technological services: research in the fields of chemicals and pharmaceuticals; research and testing services in the fields of chemicals and pharmaceuticals; research and development of new products for others in the fields of chemicals and pharmaceuticals; scientific research services; design for others in the field of DNA-based assays, DNA sequencing protocols, immunoassay and methods for drug discovery; scientific research, namely, development of pharmaceuticals or diagnostic methods; agrochemical product development for others
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, SUMMIT, NJ, US
- Celgene Corporation, Warren, NJ, US
Prosecution history
- 08 Nov 2024 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Jul 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Nov 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 29 Nov 2014 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 29 Nov 2014 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 29 Nov 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Nov 2014 — TEAS SECTION 8 & 9 RECEIVED
- 29 Nov 2010 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Nov 2010 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL